Agamon Health is making waves in the healthcare technology realm with its Patient Adherence platform, a groundbreaking initiative aimed at elevating the standards of cardiovascular care. The New York-based company, known for its utilisation of Generative AI and workflow automation, is set to expand its horizons in collaboration with the prestigious Mayo Clinic.
In a strategic move facilitated by a know-how agreement, Agamon Health is extending its expertise to the field of cardiology. The motivation behind this expansion lies in addressing the prevalent issue of non-adherence to the American Association of Cardiology guidelines for follow-up. Alarmingly, adherence rates for moderate aortic stenosis patients hover between 45 to 65%. Such lapses in follow-up care can result in severe consequences, including heightened hospitalisation, exacerbation of heart failure, and even fatalities.
In a bid to revolutionise patient adherence in cardiology follow-ups, Agamon Health is joining forces with Mayo Clinic, leveraging their combined strengths in Generative AI and workflow automation. The collaborative effort, epitomised by Agamon Coordinate, aims to "close the loop" on follow-up recommendations, ultimately enhancing patient health outcomes.
During a recent interview, Michal Meiri, CEO of Agamon Health, expressed enthusiasm for the partnership with Mayo Clinic, emphasising the significance of their joint mission. Meiri stated, "We're thrilled to collaborate with Mayo Clinic on this vital mission. The existing care gaps in cardiology are a major concern, and Agamon Health's cutting-edge technology has the potential to address them. Generative AI, coupled with workflow automation to minimise manual workflows, offers a promising avenue. By combining Mayo Clinic's renowned clinical experience with our technological expertise, our goal is to enhance operational efficiency and elevate the quality of care for patients on a global scale."
Click here to read the original news story.